Browse > Article
http://dx.doi.org/10.7314/APJCP.2014.15.22.9831

Clinical Features of Patients with Esophageal and Second Primary Cancers  

Tsai, Huang-Wen (Department of General Surgery, Far Eastern Memorial Hospital)
Chang, Chih-Chun (Department of Clinical Pathology, Far Eastern Memorial Hospital)
Sun, Jen-Tang (Department of Emergency, Far Eastern Memorial Hospital)
Liou, Ching-Biau (Department of Clinical Pathology, Far Eastern Memorial Hospital)
Lin, Hsiu-Chen (Department of Clinical Pathology, Far Eastern Memorial Hospital)
Lin, I-Hsin (Department of Clinical Pathology, Far Eastern Memorial Hospital)
Yu, Yun-Chieh (Department of Clinical Pathology, Far Eastern Memorial Hospital)
Weng, Wei-Ling (Department of Clinical Pathology, Far Eastern Memorial Hospital)
Leong, Ka-I (Department of Chest Surgery, Far Eastern Memorial Hospital)
Yen, Tzung-Hai (Division of Nephrology and Clinical Toxicology, Chang Gung Memorial Hospital, Lin-Kou Medical Center)
Wu, Jiann-Ming (Department of General Surgery, Far Eastern Memorial Hospital)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.15, no.22, 2014 , pp. 9831-9834 More about this Journal
Abstract
Background: The prevalence of esophageal cancer (EC) with second primary cancers (SPC) is increasing worldwide. This study was aimed to understand the clinical features of EC patients with SPC in the Taiwanese population. Materials and Methods: Clinical and laboratory data for 180 EC patients with or without SPC were collected between January 2009 and December 2013. Information on treatment approaches, location of SPCs and ABO blood type were also collected and stratified. Results: The most common SPC in EC patients was hypopharyngeal cancer, followed by laryngeal cancer and hepatocellular carcinoma in our study. Malignancies of colon, prostate and lung were also found. There was a significant higher portion of blood type A in the EC patients with SPC compared with those without (42.4% vs 19.5%, P=0.006). Conclusions: The frequency and SPC site distribution and blood type A should be considered in clinical evaluation of EC patients with a high risk of developing SPC in the Taiwanese population.
Keywords
Esophageal cancer; second primary cancer; blood type; Taiwan;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Caygill CP, Royston C, Charlett A, et al (2011). Barrett's, blood groups and progression to oesophageal cancer: is nitric oxide the link? Eur J Gastroenterol Hepatol, 23, 801-6.   DOI
2 Das A, Thomas S, Zablotska LB, et al (2006). Association of esophageal adenocarcinoma with other subsequent primary cancers. J Clin Gastroenterol, 40, 405-11.   DOI
3 Ge L, Wang HJ, Yin D, et al (2012). Effectiveness of 5-flurouracil-based neoadjuvant chemotherapy in locallyadvanced gastric/gastroesophageal cancer: a meta-analysis. World J Gastroenterol, 18, 7384-93.   DOI
4 Gursel B, Meydan D, Ozbek N, et al (2011). Multiple primary malignant neoplasms from the Black sea region of Turkey. J Int Med Res, 39, 667-74.   DOI   ScienceOn
5 Jingu K, Matsushita H, Takeda K, et al (2012). Long-term results of radiotherapy combined with nedaplatin and 5-fluorouracil for postoperative loco-regional recurrent esophageal cancer: update on a phase II study. BMC Cancer, 12, 542.   DOI
6 Jemal A, Siegel R, Ward E, et al (2009). Cancer statistics, 2009. CA Cancer J Clin, 59, 225-49.   DOI   ScienceOn
7 Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90.   DOI
8 Lawniczak M, Gawin A, Jaroszewicz-Heigelmann H, et al (2014). Synchronous and metachronous neoplasms in gastric cancer patients: a 23-year study. World J Gastroenterol, 20, 7480-7.   DOI
9 Luciani A, Ascione G, Marussi D, et al (2009). Clinical analysis of multiple primary malignancies in the elderly. Med Oncol, 26, 27-31.   DOI
10 Mao WM, Zheng WH, Ling ZQ (2012). Epidemiologic risk factors for esophageal cancer development. Asian Pac J Cancer Prev, 12, 2461-6.
11 Matsubara T, Yamada K, Nakagawa A, et al (2003). Risk of second primary malignancy after esophagectomy for squamous cell carcinoma of the thoracic esophagus. J Clin Oncol, 21, 4336-41.   DOI
12 Newhauser WD, Fontenot JD, Mahajan A, et al (2009). The risk of developing a second cancer after receiving craniospinal proton irradiation. Phys Med Biol, 54, 2277-91.   DOI
13 Pandeya N, Olsen CM, Whiteman DC, et al (2013). Sex differences in the proportion of esophageal squamous cell carcinoma cases attributable to tobacco smoking and alcohol consumption. Cancer Epidemiol, 37, 579-84.   DOI
14 Poon RT, Law SY, Chu KM, et al (1998). Multiple primary cancers in esophageal squamous cell carcinoma: incidence and implications. Ann Thorac Surg, 65, 1529-34.   DOI   ScienceOn
15 Prabhu A, Obi KO, Rubenstein JH et al (2014). The synergistic effects of alcohol and tobacco consumption on the risk of esophageal squamous cell carcinoma: a meta-analysis. Am J Gastroenterol, 109, 822-7.   DOI
16 Sachs RK, Shuryak I, Brenner D, et al (2007). Second cancers after fractionated radiotherapy: stochastic population dynamics effects. J Theor Biol, 49, 518-31.
17 Tang WR, Fang JY, Wu KS, et al (2014). Epidemiological characteristics and prediction of esophageal cancer mortality in China from 1991 to 2012. Asian Pac J Cancer Prev, 15, 6929-34.   과학기술학회마을   DOI
18 Song QK, Li J, Jiang HD, et al (2012). Esophageal cancer mortality during 2004-2009 in Yanting County, China. Asian Pac J Cancer Prev, 13, 5003-6.   과학기술학회마을   DOI
19 Sun P, Chen C, Zhang F, et al (2014). The ABO blood group predicts survival in esophageal squamous cell carcinoma in patients who ever smoked: a retrospective study from China. Tumour Biol, 35, 7201-8.   DOI
20 Takalkar U, Asegaonkar BN, Kodlikeri P, et al (2013). An elderly woman with triple primary metachronous malignancy: A case report and review of literature. Int J Surg Case Rep, 4, 593-6.   DOI
21 Travis LB, Demark Wahnefried W, Allan JM, et al (2013). Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivors. Nat Rev Clin Oncol, 10, 289-301   DOI
22 Warren S, Gates O (1932). Multiple primary malignant tumors: a survey of the literature and statistical study. Am J Cancer, 16, 1358-414.
23 Wood ME, Vogel V, Ng A, et al (2012). Second malignant neoplasms: Assessment and strategies for risk reduction. J Clin Oncol, 30, 3734-45.   DOI
24 Zhang Y (2013). Epidemiology of esophageal cancer. World J Gastroenterol, 19, 5598-606.   DOI
25 Zhu G, Chen Y, Zhu Z, et al (2012). Risk of second primary cancer after treatment for esophageal cancer: a pooled analysis of nine cancer registries. Disease Esophagus, 25, 505-11.   DOI